Genevieve Kanter

profgenkanter.bsky.social

13 October 2026 16:23

Patient and consumer reps on FDA advisory committees are supposed to represent the public, but do they? In our new paper in @healthaffairs.bsky.social Scholar (link in comments), we looked at the orgs that patient and consumer reps were actively involved with and tracked down their pharma donors.

Darren Dahly

statsepi.bsky.social

07 October 2026 06:21

Many papers I see: A global problem Search for modifiable "risk factors" A cohort study sorry I mean real-world data "Multivariate" regression Some associations Can't say cause Residual confounding Policy must change in ways having nothing to do with our findings More research is needed

Aaron Schwartz

aschwartz.bsky.social

02 October 2026 16:48

Our new paper on the physician fee schedule took more person-hours of research work than any other journal publication I've worked on. The study summarizes thousands of regressions we ran to provide some empirical and conceptual tools for fee schedule reforms. jamanetwork.com/journals/jam... 1/2

Andrew Partington

arpartington.bsky.social

02 October 2026 08:37

MFN pricing was projected to decrease net spending. Potential reductions in spending would be substantially greater than sales in the reference countries, suggesting that shifts in manufacturer behaviour with model implementation could reduce possible savings. www.thelancet.com/journals/lan...

Peter Tennant

pwgtennant.bsky.social

01 October 2026 20:34

"Is an ultra-processed chocolate cake materially more harmful than a home-made one?" I enjoyed contributing to this response to The Lancet series on ultra-processed foods, which outlines some key limitations in the evidence that 'ultra-processing' is specifically harmful to health.